Caribou Biosciences Alternatives & Competitors

12 companies similar to Caribou Biosciences — Clinical-stage biopharmaceutical company developing transformative therapies to...

Ensoma

The future of medicine lies within us.

51 Unknown $258.00M

Boston, United States

Biotechnology Health and Wellness +1

Legend Biotech

Multinational biopharmaceutical company focused on discovering and developing cutting-edge...

2565 Unknown $1.62B

Somerset, United States

Biotechnology Health Care +2

TScan Therapeutics

Unleash Immunity

152 IPO $662.60M

Waltham, United States

Biotechnology Health Care +2

ReCode Therapeutics

Powering the next wave of genetic medicines through superior delivery

58 Series B $347.50M

United States

Biopharma Biotechnology +1

Track all Caribou Biosciences competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Agomab

69 Series D $310.40M

Ghent, Belgium

Biotechnology Health Care +1

miRecule, Inc.

RNA Therapeutics

12 Seed $7.20M

Gaithersburg, United Stat...

Biopharma Biotechnology +1

Ipsen

Engineers and develops bacterial-based protein therapeutics for the treatment of neurologi...

6518 Acquired $277.40M

Paris, France

Biotechnology Pharmaceutical

Nuvamid

A clinical stage biotech focused on the research and use of nucleotides, as therapeutics f...

Nyon, Switzerland

Health Care Manufacturing +1

SanegeneBio

Sanegene Bio is committed to advancing transformative RNAi therapies that address global...

28 Series B $190.00M

Woburn, United States

Ajax Therapeutics

Biopharmaceutical company developing next generation JAK inhibitors for patients with myel...

12 Acquired $2.44B

Biotechnology Life Sciences

Arbor Biotechnologies

Genetic medicines for genetic diseases

103 Unknown $304.50M

Cambridge, United States

Biopharma Biotechnology +1

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...

San Diego, United States

Biopharma Biotechnology +1

About Caribou Biosciences

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases

Services

Development of genome-edited cell therapies, CRISPR-based technology solutions, Clinical research and trials

Target Customers

Patients with devastating human diseases, Healthcare providers, Biopharmaceutical stakeholders

Taxonomy

CRISPR Genome Editing, Biopharmaceuticals, Cell Therapy, Allogeneic CAR-T, Hematologic Malignancies, Autoimmune Diseases, Cellular Engineering, Genome Engineering, Therapeutics Development, Clinical-Stage Company, Oncology, Agricultural Biotechnology, Industrial Biotechnology, CRISPR-Cas9 Technology, Next-Generation Therapies

Business Model

B2B, Platform, B2B2C

Revenue Model

Licensing, Project Based, Service Fee

Frequently Asked Questions

Top alternatives to Caribou Biosciences include Ensoma, Legend Biotech, TScan Therapeutics, ReCode Therapeutics, Agomab. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Caribou Biosciences based on industry overlap, target customers, and business model.

Clinical-stage biopharmaceutical company developing transformative therapies to treat devastating human diseases

Don't just read about them. Follow them.

BounceWatch watches Caribou Biosciences and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Caribou Biosciences Profile Ensoma Alternatives Legend Biotech Alternatives TScan Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Caribou Biosciences on 3 Jul 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.